These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32913336)

  • 1. Author Correction: Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
    Camellino D; Matteson EL; Buttgereit F; Dejaco C
    Nat Rev Rheumatol; 2020 Nov; 16(11):662. PubMed ID: 32913336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of polymyalgia rheumatica/giant cell arteritis.
    Salvarani C; Macchioni L; Olivieri I; Cantini F; Boiardi L
    BioDrugs; 1998 Jan; 9(1):25-32. PubMed ID: 18020554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970.
    Hunder GG
    Mayo Clin Proc; 2006 Aug; 81(8):1071-83. PubMed ID: 16901030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyalgia rheumatica: 125 years of epidemiological progress?
    Rooney PJ; Rooney J; Balint G; Balint P
    Scott Med J; 2015 Feb; 60(1):50-7. PubMed ID: 25201886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
    Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.
    Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
    Ann Intern Med; 1994 Oct; 121(7):484-91. PubMed ID: 8067646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu's arteritis.
    Hellmann DB
    Curr Opin Rheumatol; 1993 Jan; 5(1):25-32. PubMed ID: 8094625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyalgia rheumatica: 125 years of progress?
    Rooney PJ; Rooney J; Balint G; Balint P
    Scott Med J; 2014 Nov; 59(4):220-8. PubMed ID: 25201885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M
    Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.
    Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM
    Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant cell arteritis.
    Nordborg E; Nordborg C; Bengtsson BA
    Curr Opin Rheumatol; 1992 Feb; 4(1):23-30. PubMed ID: 1543659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of giant cell arteritis to polymyalgia rheumatica.
    Healey LA
    Baillieres Clin Rheumatol; 1991 Dec; 5(3):371-8. PubMed ID: 1807815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia rheumatica and giant cell arteritis.
    Unwin B; Williams CM; Gilliland W
    Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.
    Muratore F; Pipitone N; Hunder GG; Salvarani C
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S86-92. PubMed ID: 24129145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and management of polymyalgia rheumatica and giant cell arteritis.
    Caylor TL; Perkins A
    Am Fam Physician; 2013 Nov; 88(10):676-84. PubMed ID: 24364483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases.
    Arai T; Tanaka R; Kaburaki T
    Ocul Immunol Inflamm; 2018; 26(5):779-782. PubMed ID: 28282736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].
    Hulin C; Hachulla E; Michon-Pasturel U; Hatron PY; Masy E; Gillot JM; Caron C; Arvieux J; Flipo RM; Devulder B
    Rev Med Interne; 1999 Aug; 20(8):659-63. PubMed ID: 10480168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of giant cell arteritis and polymyalgia rheumatica.
    Meskimen S; Cook TD; Blake RL
    Am Fam Physician; 2000 Apr; 61(7):2061-8, 2073. PubMed ID: 10779249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica and giant-cell arteritis.
    Salvarani C; Cantini F; Hunder GG
    Lancet; 2008 Jul; 372(9634):234-45. PubMed ID: 18640460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.